Towards understanding alzheimer's disease: An overview

Research Journal of Pharmaceutical, Biological and Chemical Sciences

Volumn 4, Issue 4, 2013, Pages 286-298

  Bagad, Mayur ^a   Chowdhury, Debajyoti ^a   Khan, Zaved Ahmed ^a  

^a VIT UNIVERSITY   (India)

Author keywords

Amyloid (A ) peptides, Alzheimer's disease (AD).

Indexed keywords

AMYLOID BETA PROTEIN; MESSENGER RNA; TAU PROTEIN;

ALTERNATIVE MEDICINE; ALZHEIMER DISEASE; AMNESIA; ARTICLE; CASE MANAGEMENT; CELL THERAPY; COMORBIDITY; DAILY LIFE ACTIVITY; DECISION MAKING; DELIRIUM; DEMENTIA; DISORIENTATION; DYSGRAPHIA; ENVIRONMENTAL FACTOR; HUMAN; INCIDENCE; INDIAN; INFORMATION RETRIEVAL; MOOD DISORDER; NEUROFIBRILLARY TANGLE; PERSONALITY DISORDER; PREVALENCE; PROBLEM SOLVING; PSYCHOSOCIAL WITHDRAWAL; RISK FACTOR; SENILE PLAQUE; SPEECH DISORDER; URBAN RURAL DIFFERENCE; VASCULAR AMYLOIDOSIS; VISION;

EID: 84891132615     PISSN: None     EISSN: 09758585     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. https://apps.who.int/inf-fs/en/fact135.html.
2. http://www.alz.org/alzheimers/disease/facts/and/figures.asp.
3. World Health Organization, Active Ageing: a Policy Framework, World Health Organization 2002, Geneva, Switzerland.
4. LE Hebert, PA Scherr, JL Bienias, DA Bennett, and DA Evans. Arch Neurol 2000; 60: 1119-1122.
5. Chandra V, Ganguli M, Pandav R et al. Neurology 1998; 51:1000-1008.
6. Mittal G, Carswell H. Brett R. et al. J Cont Release 2011; 150: 220-228.
7. Jue He, Huanmin Lu and Bin Yan. Neurology Aging 2009; 30: 1205-1216.
8. Smith C. U. M. John Wiley & Sons, Ltd, 2002.
9. Bayreuther K and Masters C.L. Brain Res Rev 1991; 16: 86-88.
10. www.nia.nih.gov/Alzheimers/Publications/adfact.htm.
11. www.alz.org/alzheimers_disease_facts_figures.asp.
12. http://www.webmd.com/alzheimers/guide/alzheimers-types
13. http://www.nia.nih.gov/alzheimers/publication/alzheimers-disease-genetics-fact-sheet
14. Ferri C.P, Prince M, Brayne C. et al. Lancet 2005; 366: 2112-2117.
15. Dias A and Patel V. Ind J Psych 2009; 51(5): 93-97.
16. Shaji KS. Ind J Psych 2009; 51(5): 5-7.
17. Satishchandra P, Yasha T.C, Shankar L. et al. Alzheimer Disease and Associated Disorders 1997; 11(2): 107-109.
18. Jotheeswaran A.T. Alzheimer's & Related Disorders Society of India 2010; Thrissur.
19. Llibre J.J, Ferri C.P, Acosta D, Guerra M et al. Lancet 2008; 372: 464-474.
20. Shaji S, Bose S, and Verghese A. British J Psyc 2005; 186:136-140.
21. Das S.K, Biswas A, Roy T. et al. Ind J Med Res 2006; 124(2): 163-172.
22. Prince M, Ferri C.P, Acosta D. et al. BMC Public Health 2007; 7:23-31.
23. Mathuranath P.S, Cherian P.J, Mathew R. et al. Int J Ger Psyc 2010; 25(3): 290-297.
24. COHEN L. Med Anthrop Quart 1995; 3: 334.
25. Shaji S, Promodu K, Abraham T and Roy K.J. British J Psyc 1996; 168: 745-749.
26. Rajkumar S, Kumar S and Thara R. Int J Ger Psyc 1997; 12(7): 702-707.
27. Alloul K, Sauriol L, Kennedy W, et al. Arch Geront Geriat 1998; 27: 189-221.
28. Relkin N. R, Szabo P, Adamiak B, et al. Neurob Aging 2009; 30: 1728-1736.
29. http://psychology.jrank.org/pages/509/Psychoactive-Drugs.html
30. Ling-Feng Jiang, Tian-Ming Yao, Zhi-Liang Zhu, et al. Bioch et Biophy Acta 2007; 1774: 1414-1421.
31. Kazuhiro I, Kazuma M, Masuda Y, et al. J Biosci Bioeng 2005; 99(5): 437-447.
32. Goate A, Chartier-Harlin M, Mullan M. et al. Nature 1991; 349: 704-706.
33. Iwatsubo T, Odaka A, Suzuki N, et al. Neuron 1994; 13: 45-53.
34. Iwatsubo T, Mann D, Odaka A, et al. Ann neurol 1995; 37: 294-299.
35. Vassar R, Bennett B, Babu-Khan S, et al. Science 1999; 286: 735- 741.
36. Davis J, and Van Nostrand. Proceeding of National Academy of Sciences 1996; 93: 2996-3000.
37. Jarrett J.T, and Lansbury P.T. Cell 1993; 73: 1055-1058.
38. Bucciantini M, Giannoni E, Baroni F, et al. Nature 2002; 416: 507-511.
39. Ludovic M, Xenia L and Faraj Terro. Neurochem Int 2011; 58: 458-471.
40. Maccioni R.B, Faris G, Morales I, and Navarrete L. Arch Med Res 2010; 41:226- 231.
41. Morales I, Farias G, Maccioni R.B. Neuroimmunomodulation 2010; 17: 202- 204.
42. Cleveland D.W, Hwo S.Y and Kirschner M.W. J Mol Biol 1997; 116: 207-225.
43. Almos P.Z, Horvath S, Czibula A, et al. Heredity 2008; 101: 416-419.
44. Buee L, Bussiere T, Buee-Scherrer V and Delacourte A. Brain Res Rev 2000; 33: 95-130.
45. Panda D, Samuel J.C, Massie M, Feinstein S.C, and Wilson L. Proceeding of the national academy of sciences U. S. A. 2003; 100: 9548-9553.
46. Ozer R. S, and Halpain S. Mol biol cell 2000; 11: 3573-3587.
47. Dickey C.A, Kamal A, Lundgren K. et al. J Clin Invest 2007; 117: 648-658.
48. Gendron T.F. and Petrucelli L. Mol Neurodeg 2009; 4: 13.
49. Mona Mehta, Abdu Adem, and Marwan Sabbagh. Int J Alz Dis 2011; 1:1-9.
50. Upadhyaya P, Seth V and Ahmad M. Afr J Pharm Pharmacol 2010; 4(6): 408-421.
51. Mason A, Yuan S.H, Bardy C, et al. Nature 2012; 482: 216-220.
52. Relkina N.R, Szaboa P, Adamiaka B, et al. Neurob Aging 2009; 30:1728-1736.